UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

The Lancet (British edition), 1989-09, Vol.334 (8663), p.580-585

1989

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESAR)

Anti-cancer drugs, 2004-01, Vol.15 (1), p.15-22

2004

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

The New England journal of medicine, 1997-05, Vol.336 (18), p.1290-1298

1997

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3632: Nonclinical pharmacokinetics and safety of Angiocal, the first VEGF-A-specific alternative scaffold protein entering clinical development for cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3632-3632

2011

Link zum Volltext

Verfügbarkeit prüfen

Flow Cytometry for Clinical Estimation of Circulating Hematopoietic Progenitors for Autologous Transplantation in Cancer Patients

Blood, 1991-01, Vol.77 (2), p.400-409

1991

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma

Journal of clinical oncology, 1990-05, Vol.8 (5), p.768-778

1990

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor as Adjunct to Induction Treatment of High-Grade Malignant Non-Hodgkin's Lymphomas

Blood, 1993-10, Vol.82 (8), p.2329-2339

1993

Link zum Volltext

Verfügbarkeit prüfen

Ia-bearing bone marrow-cultured macrophages induce antigen-specific helper T cells for antibody synthesis

The Journal of immunology (1950), 1979-08, Vol.123 (2), p.612

1979

Link zum Volltext

Verfügbarkeit prüfen

CORRECTION OF GRANULOCYTOPENIA IN FELTY'S SYNDROME BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR. SIMULTANEOUS INDUCTION OF INTERLEUKIN-6 RELEASE AND FLARE-UP OF THE ARTHRITIS

Blood, 1989-12, Vol.74 (8), p.2769-2770

1989

Link zum Volltext

Verfügbarkeit prüfen

A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma

Cancer research (Chicago, Ill.), 1991, Vol.51 (1), p.116-122

1991

Link zum Volltext

Verfügbarkeit prüfen

Short‐term administration of granulocyte‐macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs

Cancer, 1993-11, Vol.72 (10), p.2970-2973

1993

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever

European journal of cancer & clinical oncology, 1990, Vol.26 (9), p.932-936

1990

Link zum Volltext

Verfügbarkeit prüfen

The side-effect profile of GM-CSF

Infection, 1992-01, Vol.20 Suppl 2 (2), p.S124-S127

1992

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Effect of Human Granulocyte-Macrophage Colony-Stimulating Factor on Megakaryocytopoiesis

Blood, 1991-03, Vol.77 (6), p.1191-1194

1991

Link zum Volltext

Verfügbarkeit prüfen

Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy

Leukemia research, 1993-02, Vol.17 (2), p.175-185

1993

Link zum Volltext

Verfügbarkeit prüfen

In vivo priming of human normal neutrophils by granulocyte‐macrophage colony stimulating factor: effect on the production of platelet activating factor

British journal of haematology, 1990-07, Vol.75 (3), p.333-339

1990

Link zum Volltext

Verfügbarkeit prüfen

Role of human recombinant GM-CSF in the prevention and treatment of leukopenia with special reference to infectious diseases

Diagnostic microbiology and infectious disease, 1990-09, Vol.13 (5), p.391-396

1990

Link zum Volltext

Verfügbarkeit prüfen

Clinical Experience with Escherichia coli rHuGM-CSF

International Review of Experimental Pathology, 1993, Vol.34, p.209-216

1993

Link zum Volltext

Verfügbarkeit prüfen

Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Reduces Pancytopenia After Rescue Therapy in a Patient with Hodgkin's Lymphoma

Leukemia & lymphoma, 1990, Vol.3 (1), p.61-66

1990

Link zum Volltext

Verfügbarkeit prüfen

Ia determinants on macrophages: significance and role in the immune response

Advances in experimental medicine and biology, 1982, Vol.155, p.579

1982

Link zum Volltext

Verfügbarkeit prüfen

Differentiation Markers and Accessory Function of Murine Macrophages Derived from Cultured Bone-Marrow Stem Cells

Immunobiology (1979), 1983-02, Vol.164 (1), p.63-67

1983

Link zum Volltext

Verfügbarkeit prüfen

Regulation of osteoclast function and bone mass by RAGE

The Journal of experimental medicine, 2006-04, Vol.203 (4), p.1067-1080

2006

Link zum Volltext

Verfügbarkeit prüfen

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

The Journal of clinical investigation, 2004-06, Vol.113 (11), p.1641-1650

2004

Link zum Volltext

Verfügbarkeit prüfen

RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy

The American journal of pathology, 2003-04, Vol.162 (4), p.1123-1137

2003

Link zum Volltext

Verfügbarkeit prüfen

RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin Polypeptides

Cell, 1999-06, Vol.97 (7), p.889-901

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)
Bücher
(1)

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESAR)

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

Abstract 3632: Nonclinical pharmacokinetics and safety of Angiocal, the first VEGF-A-specific alternative scaffold protein entering clinical development for cancer

Flow Cytometry for Clinical Estimation of Circulating Hematopoietic Progenitors for Autologous Transplantation in Cancer Patients

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma

Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor as Adjunct to Induction Treatment of High-Grade Malignant Non-Hodgkin's Lymphomas

Ia-bearing bone marrow-cultured macrophages induce antigen-specific helper T cells for antibody synthesis

CORRECTION OF GRANULOCYTOPENIA IN FELTY'S SYNDROME BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR. SIMULTANEOUS INDUCTION OF INTERLEUKIN-6 RELEASE AND FLARE-UP OF THE ARTHRITIS

A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma

Short‐term administration of granulocyte‐macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever

The side-effect profile of GM-CSF

In Vivo Effect of Human Granulocyte-Macrophage Colony-Stimulating Factor on Megakaryocytopoiesis

Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy

In vivo priming of human normal neutrophils by granulocyte‐macrophage colony stimulating factor: effect on the production of platelet activating factor

Role of human recombinant GM-CSF in the prevention and treatment of leukopenia with special reference to infectious diseases

Clinical Experience with Escherichia coli rHuGM-CSF

Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Reduces Pancytopenia After Rescue Therapy in a Patient with Hodgkin's Lymphoma

Ia determinants on macrophages: significance and role in the immune response

Differentiation Markers and Accessory Function of Murine Macrophages Derived from Cultured Bone-Marrow Stem Cells

Regulation of osteoclast function and bone mass by RAGE

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy

RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin Polypeptides

Suchergebnisse filtern